FKnol.com

Financial Knowledge & Information Portal

Bio-Techne (TECH) Company Profile

Updated Aug 8, 2019
Bio-Techne has the following business profile:
Company's Full Name:Bio-Techne Corp
Short Name:Bio-Techne
Trading Ticker Symbol:TECH
Primary Exchange:NASDAQ
Headquarter City/Country:Minnesota, MN
Primary Industry Sector:Health Care
Seconday Sub-sector:Biotech Biological Products
Main Business Areas: Health Care, Biotech Biological Products, Biotech Products, Biotechnology, Biotech
Dividend Payments:Dividend History

Market and Trading Information for Bio-Techne

The following details were available for trading and market data about the stock of Bio-Techne as of writing:
Current Share Price:$195.67
Previous Year's Closing Price:$144.72
Percentage Price Change (YTD):35.21%
Market Cap:$7.41 billion
52-week Price Range:$132.75 - $217.16
Dividend Per Share:$1.28
EPS (TTM):3.13
Price-Earnings (Trailing):62.43
Price-Earnings (Forward):34.09

Company Profile and Business Description for Bio-Techne

Bio-Techne Corporation, incorporated on July 17, 1981, develops, manufactures and sells biotechnology reagents and instruments for the research and clinical diagnostic markets. The Company operates through three segments: Biotechnology, Clinical Controls and Protein Platforms. The Biotechnology segment develops, manufactures and sells biotechnology research and diagnostic products across the world. The Clinical Controls segment develops and manufactures controls, calibrators, immunoassays and other reagents for the global clinical market. The Protein Platforms segment develops and commercializes systems and consumables for protein analysis.

Biotechnology Segment

The Biotechnology segment supplies specialized proteins, such as cytokines, growth factors, immunoassays, antibodies and related reagents, to the biotechnology research community. It develops and manufactures a range of cytokines, growth factors and enzymes, extracted from natural sources or produced using recombinant de-oxy ribonucleic acid (DNA) technology. The Company produces polyclonal antibodies in animals (primarily goats, sheep and rabbits), purifying them from the animals' blood. It derives monoclonal antibodies from immortalized rodent cell lines using hybridoma technology, isolating them from cell culture medium, or it manufactures them through recombinant DNA technology. The flow cytometry product line includes fluorochrome labeled antibodies and kits that are used to determine the immuno-phenotypic properties of cells from different tissues.

The Company markets a range of immunoassays on different testing platforms, including microtiter-plate based kits sold under the trade name Quantikine, multiplex immunoassays based on encoded bead technology and immunoassays based on planar spotted surfaces and microfluidic-based multiplex immunoassays on automated testing platform. The Company's small molecule chemically-based products include small natural or synthetic chemical compounds used by investigators as agonists, antagonists and/or inhibitors of various biological functions. The Company sells its biotechnology products directly to customers located in North America, western Europe and China. It also sells through third party distributors in China, Japan, southern and eastern Europe, and the rest of the world.

The Company competes with GE Healthcare Life Sciences, BD Biosciences, Merck KGaA/EMD Chemicals, Inc., PeproTech, Inc., Santa Cruz Biotechnology, Inc., Abcam plc., Thermo Fisher Scientific, Inc., Cayman Chemical Company and Enzo Biochem, Inc.

Clinical Controls Segment

The Company derives its hematology controls and calibrators from various cellular components of blood, which have been stabilized. The Company also offers clinical controls for blood glucose and blood gas devices, as well as coagulation device control products. In addition, the Company also develops and supplies bulk purified proteins, enzymes, disease-state plasmas, infectious disease antigens and processed serums to the clinical diagnostic industry across the world. The Company supplies these reagents in various formats, including liquid, lyophilized and powder form.

The Company competes with Abbott Diagnostics, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Streck, Inc., Siemens Healthcare Diagnostics Inc., Sysmex Corporation, SeraCare Life Sciences, Inc., HyTest Ltd and Thermo Fisher Scientific, Inc.

Protein Platforms Segment

The Company offers Simple Western platform and SimplePlex Platform. Simple Western platform is an automated Western blot analytical technique, which identifies and quantifies a protein of interest in a sample. The Simple Western product lines transform the Western into a real protein analytical tool. SimplePlex Platform is a common assay used in research and clinical diagnostics is the enzyme-linked immunosorbent assay (ELISA). The SimplePlex platform is a transformative immunoassay technology, which integrates microfluidic cartridge with an analyzer to deliver an immunoassay system. SimplePlex assays are automated, multi-analyte immunoassays that permit the customer to run multiple samples while interrogating multiple analytes in approximately one hour. The Company's Biologics tools provide the researchers to interrogate protein purity and identify contaminants during the development and production of biologics.

The Company's iCE3 system is an analytical tool that measures the charge heterogeneity of proteins. Its micro-flow imaging (MFI) platform measures the size, shape, count and concentration of particles that may be present in biologic solutions. The Company also offers a biologics product, Maurice, which profiles identity, purity and hetergenity of biopharmaceuticals in one system. In addition, the Company offers Single Cell Western Platform, which performs western blot assays on individual cells versus an entire cell population. The Company sells protein platforms products directly to customers located in North America, western Europe and Japan. It also sells through third party distributors in China, southern Europe and the rest of the world.

The Company competes with Bio-Rad Laboratories, Inc., GE Healthcare, Merck KGaA, PerkinElmer, Thermo Fisher Scientific, Inc., Meso Scale Discovery, Luminex, Millipore, MDS Analytical Technologies, Tecan BioTek, Agilent Technologies, Danaher, Shimadzu and Waters.

614 McKinley Pl NE

Peer / Competitor Companies of Biotech Biological Products Sector

Along with Bio-Techne Corp, the following other peer (competitor) companies also exist within the same Biotech Biological Products - Health Care sector whose company profile and dividend history is as follows:

▶ Acceleron Pharma (XLRN): Acceleron Pharma Inc., incorporated on June 13, 2003, is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutics to treat serious and rare ....See Detailed Company Profile  and Dividend History.

▶ Acorda Therapeutics (ACOR): Acorda Therapeutics, Inc., incorporated on March 17, 1995, is a biopharmaceutical company. The Company focuses on developing therapies that restore function and improve the lives of people with neurological disorders. ....See Detailed Company Profile  and Dividend History.

▶ Adaptimmune Therapeutics (ADAP): Adaptimmune Therapeutics plc, incorporated on December 03, 2014, is a clinical-stage biopharmaceutical company. The Company is focused on cancer immunotherapy products based on its Specific Peptide Enhanced Affinity Receptor (SPEAR) ....See Detailed Company Profile  and Dividend History.

▶ ADMA Biologics (ADMA): ADMA Biologics, Inc., incorporated on June 2, 2006, is a late-stage biopharmaceutical company that develops, manufactures and intends to market specialty plasma-based biologics for the treatment and prevention of infectious ....See Detailed Company Profile  and Dividend History.

▶ Adverum Biotechnologies (ADVM): Adverum Biotechnologies, Inc., formerly Avalanche Biotechnologies, Inc., incorporated on July 17, 2006, is a gene therapy company. The Company is engaged in discovering and developing medicines to patients suffering from ....See Detailed Company Profile  and Dividend History.

▶ Aerie Pharma (AERI): Aerie Pharmaceuticals, Inc., incorporated on June 22, 2005, is a clinical-stage pharmaceutical company. The Company is engaged in the discovery, development and commercialization of therapies for the treatment of patients ....See Detailed Company Profile  and Dividend History.

▶ Aevi Genomic Medicine (GNMX): Aevi Genomic Medicine, Inc., formerly Medgenics, Inc., incorporated on January 27, 2000, is focused on genomic medicine. The Company is engaged in unlocking the potential of genomic medicine to translate ....See Detailed Company Profile  and Dividend History.

▶ Agenus (AGEN): Agenus Inc., a clinical-stage immuno-oncology company, focuses on the discovery and development of therapies that engage the body's immune system to fight cancer. The company offers Retrocyte Display,....See Detailed Company Profile  and Dividend History.

▶ Amgen (AMGN): Amgen Inc., incorporated on October 31, 1986, is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. The Company operates in the human therapeutics segment. The ....See Detailed Company Profile  and Dividend History.

▶ AmpliPhi Biosciences (APHB): AmpliPhi Biosciences Corporation, incorporated on March 9, 1989, is a biotechnology company. The Company is focused on the discovery, development and commercialization of phage therapeutics. The Company is engaged in ....See Detailed Company Profile  and Dividend History.

▶ Apollo Endosurgery (APEN): Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. It develops and distributes devices for minimally invasive surgica....See Detailed Company Profile  and Dividend History.

▶ Applied Genetic (AGTC): Applied Genetic Technologies Corporation, incorporated on October 24, 2003, is a clinical-stage biotechnology company. The Company develops gene therapy products designed to manage the lives of patients with severe diseases ....See Detailed Company Profile  and Dividend History.

▶ Aptose Biosciences (APTO): Aptose Biosciences Inc. (Aptose), incorporated on November 1, 2006, is a clinical-stage biotechnology company. The Company is engaged in the development of anticancer drugs that target specific epigenetic processes and ....See Detailed Company Profile  and Dividend History.

▶ ARIAD Pharma (ARIA): ....See Detailed Company Profile  and Dividend History.

▶ Asterias Biotherapeutics (AST): Asterias Biotherapeutics, Inc., incorporated on October 24, 2012, is a biotechnology company. The Company is engaged in developing and commercializing therapies in the fields of cell therapy and regenerative medicine. ....See Detailed Company Profile  and Dividend History.

▶ Atara Biotherapeutics (ATRA): Atara Biotherapeutics, Inc., incorporated on August 22, 2012, is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies for patients with severe and life-threatening diseases. The Company operates ....See Detailed Company Profile  and Dividend History.

▶ aTyr Pharma (LIFE): aTyr Pharma, Inc., incorporated on October 8, 2005, is a clinical-stage biotherapeutics company. The Company is engaged in the discovery and clinical development of medicines for patients suffering from severe, ....See Detailed Company Profile  and Dividend History.

▶ Audentes Therapeutics (BOLD): Audentes Therapeutics, Inc., incorporated on November 13, 2012, is an early-stage biotechnology company. The Company is focused on developing and commercializing gene therapy products for patients suffering from serious, life-threatening ....See Detailed Company Profile  and Dividend History.

▶ AveXis (AVXS): AveXis, Inc., incorporated on March 10, 2010, is a clinical-stage gene therapy company. The Company operates through the developing and commercializing gene therapy treatments for patients suffering from neurological genetic ....See Detailed Company Profile  and Dividend History.

▶ Aviragen Therapeutics (AVIR): Aviragen Therapeutics, Inc., formerly Biota Pharmaceuticals, Inc., incorporated on March 14, 1969, is focused on the discovery and development of direct-acting antivirals to treat infections that affect patients globally. The ....See Detailed Company Profile  and Dividend History.

... See Full List of All Stocks of Biotech Biological Products Sector.

Stock List of Other Health Care Sub-sectors

▶ Stocks of Sector

▶ Stocks of Biotech Sector

▶ Stocks of Biotech Apparatus Sector

▶ Stocks of Biotech Diagnostics Sector

▶ Stocks of Biotech Products Sector

▶ Stocks of Biotech Research Sector

▶ Stocks of Drug Delivery Sector

▶ Stocks of Drug Development Sector

▶ Stocks of Drug Manufacturer Sector

▶ Stocks of Health Care Sector

▶ Stocks of Health Care Equipment and Services Sector

▶ Stocks of Hospital and Nursing Management Sector

▶ Stocks of Industrial Specialties Sector

▶ Stocks of Major Pharmaceuticals Sector

▶ Stocks of Medical Dental Instruments Sector

▶ Stocks of Medical Electronics Sector

▶ Stocks of Medical Nursing Services Sector

▶ Stocks of Medical Products Sector

▶ Stocks of Medical Specialities Sector

▶ Stocks of Ophthalmic Goods Sector

▶ Stocks of Other Pharmaceuticals Sector

▶ Stocks of Precision Instruments Sector


Stock List of Other Top-level Sectors

▶ Stocks of Sector

▶ Stocks of Basic Industries Sector

▶ Stocks of Basic Materials Sector

▶ Stocks of Capital Goods Sector

▶ Stocks of Communication Services Sector

▶ Stocks of Consumer Cyclical Sector

▶ Stocks of Consumer Defensive Sector

▶ Stocks of Consumer Durables Sector

▶ Stocks of Consumer Non-Durables Sector

▶ Stocks of Consumer Services Sector

▶ Stocks of Energy Sector

▶ Stocks of Finance Sector

▶ Stocks of Financial Services Sector

▶ Stocks of Health Care Sector

▶ Stocks of Industrials Sector

▶ Stocks of Miscellaneous Sector

▶ Stocks of Public Utilities Sector

▶ Stocks of Real Estate Sector

▶ Stocks of Services Sector

▶ Stocks of Technology Sector

▶ Stocks of Transportation Sector

▶ Stocks of Utilities Sector